Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153


IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.

Wang X, Wang H, Liu MQ, Li JL, Zhou RH, Zhou Y, Wang YZ, Zhou W, Ho WZ.

Front Immunol. 2017 Mar 6;8:210. doi: 10.3389/fimmu.2017.00210. eCollection 2017 Mar 6.


Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.

Ginting TE, Suryatenggara J, Christian S, Mathew G.

Oncolytic Virother. 2017 Mar 3;6:21-30. doi: 10.2147/OV.S123292.


Interferon Lambda: Modulating Immunity in Infectious Diseases.

Syedbasha M, Egli A.

Front Immunol. 2017 Feb 28;8:119. doi: 10.3389/fimmu.2017.00119. Review.


The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Bruening J, Weigel B, Gerold G.

J Immunol Res. 2017;2017:7232361. doi: 10.1155/2017/7232361. Epub 2017 Feb 1. Review.


Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.

Baldridge MT, Lee S, Brown JJ, McAllister N, Urbanek K, Dermody TS, Nice TJ, Virgin HW.

J Virol. 2017 Mar 13;91(7). pii: e02079-16. doi: 10.1128/JVI.02079-16.


A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection.

Saxena K, Simon LM, Zeng XL, Blutt SE, Crawford SE, Sastri NP, Karandikar UC, Ajami NJ, Zachos NC, Kovbasnjuk O, Donowitz M, Conner ME, Shaw CA, Estes MK.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E570-E579. doi: 10.1073/pnas.1615422114.


IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.

Lasfar A, Zloza A, de la Torre A, Cohen-Solal KA.

Front Immunol. 2016 Dec 15;7:598. doi: 10.3389/fimmu.2016.00598. Review.


STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.

Yamauchi S, Takeuchi K, Chihara K, Honjoh C, Kato Y, Yoshiki H, Hotta H, Sada K.

Sci Rep. 2016 Dec 8;6:38336. doi: 10.1038/srep38336.


Immune Responses to Influenza Virus and Its Correlation to Age and Inherited Factors.

Bahadoran A, Lee SH, Wang SM, Manikam R, Rajarajeswaran J, Raju CS, Sekaran SD.

Front Microbiol. 2016 Nov 22;7:1841. Review.


Lambda Interferons: New Cytokines with Old Functions.

Hamming OJ, Gad HH, Paludan S, Hartmann R.

Pharmaceuticals (Basel). 2010 Mar 25;3(4):795-809. Review.


DNA Damage Response and Immune Defense: Links and Mechanisms.

Nakad R, Schumacher B.

Front Genet. 2016 Aug 9;7:147. doi: 10.3389/fgene.2016.00147. Review.


What Do We Know about How Hantaviruses Interact with Their Different Hosts?

Ermonval M, Baychelier F, Tordo N.

Viruses. 2016 Aug 11;8(8). pii: E223. doi: 10.3390/v8080223. Review.


Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway.

Oon S, Wilson NJ, Wicks I.

Clin Transl Immunology. 2016 May 13;5(5):e79. doi: 10.1038/cti.2016.26. Review.


The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection.

Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H, Hashemi M.

Hepat Mon. 2016 Mar 5;16(3):e34266. doi: 10.5812/hepatmon.34266.


Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.

Wang CH, Hwang Y, Lin E.

J Exp Pharmacol. 2010 Jun 23;2:73-82. Review.


Microbial pathogenesis and type III interferons.

Cohen TS, Parker D.

Cytokine Growth Factor Rev. 2016 Jun;29:45-51. doi: 10.1016/j.cytogfr.2016.02.005.


Parainfluenza Virus 3 Blocks Antiviral Mediators Downstream of the Interferon Lambda Receptor by Modulating Stat1 Phosphorylation.

Eberle KC, McGill JL, Reinhardt TA, Sacco RE.

J Virol. 2015 Dec 30;90(6):2948-58. doi: 10.1128/JVI.02502-15.


Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.

Li L, Ulrich R, Baumgärtner W, Gerhauser I.

J Neuroinflammation. 2015 Dec 24;12:242. doi: 10.1186/s12974-015-0462-x.


Innate Immunity and Immune Evasion by Enterovirus 71.

Pathinayake PS, Hsu AC, Wark PA.

Viruses. 2015 Dec 14;7(12):6613-30. doi: 10.3390/v7122961. Review.

Supplemental Content

Support Center